Assignment: Endoplasmic Reticulum - The
Cellular Factory
Introduction
The endoplasmic reticulum (ER) is a critical organelle in eukaryotic cells, involved in the
synthesis of proteins and lipids, as well as the detoxification of harmful substances. The ER is
classified into two distinct regions based on structure and function: the Rough Endoplasmic
Reticulum (Rough ER) and the Smooth Endoplasmic Reticulum (Smooth ER). This assignment
will explore the structure, function, and significance of the ER in cellular activities.
Structure of the Endoplasmic Reticulum
1. General Structure
The ER is an extensive network of membranes forming tubules, vesicles, and flattened sacs
called cisternae. It is continuous with the nuclear envelope and extends throughout the
cytoplasm.
2. Rough Endoplasmic Reticulum (Rough ER)
Appearance: The Rough ER appears "rough" due to the presence of ribosomes on its
cytoplasmic surface.
Structure: It consists of flattened sacs with ribosomes attached to the outer surface.
Function: Primarily involved in the synthesis of proteins destined for secretion,
incorporation into the cell membrane, or lysosomes.
3. Smooth Endoplasmic Reticulum (Smooth ER)
Appearance: The Smooth ER lacks ribosomes, giving it a "smooth" appearance.
Structure: Composed of more tubular and branched structures.
Function: Involved in lipid synthesis, carbohydrate metabolism, detoxification of drugs
and poisons, and calcium ion storage.
Functions of the Endoplasmic Reticulum
1. Rough Endoplasmic Reticulum (Rough ER)
Protein Synthesis
Translation: Ribosomes on the Rough ER translate mRNA into polypeptide chains.
Folding and Modifications: Newly synthesized polypeptides enter the ER lumen, where
they fold into their functional conformations. Post-translational modifications, such as
glycosylation, also occur.
Quality Control: The ER has mechanisms to ensure only properly folded and assembled
proteins are transported to their destinations.
Transport and Packaging
Vesicle Formation: Proteins are packaged into vesicles that bud from the ER and are
transported to the Golgi apparatus for further processing and sorting.
2. Smooth Endoplasmic Reticulum (Smooth ER)
Lipid Synthesis
Phospholipids and Steroids: The Smooth ER synthesizes phospholipids and cholesterol,
essential components of cell membranes.
Triglycerides: Also involved in the synthesis of triglycerides, which are important for
energy storage.
Detoxification
Enzymatic Detoxification: The Smooth ER contains enzymes that detoxify drugs and
harmful substances by converting them into more water-soluble compounds for
excretion.
Calcium Storage
Calcium Sequestration: The Smooth ER stores calcium ions, which are released into the
cytoplasm as second messengers in various signaling pathways, particularly in muscle
contraction.
Carbohydrate Metabolism
Glycogen Breakdown: In liver cells, the Smooth ER is involved in the breakdown of
glycogen into glucose.
Significance of the Endoplasmic Reticulum
1. Cellular Homeostasis
The ER plays a crucial role in maintaining cellular homeostasis by regulating the synthesis and
distribution of proteins and lipids.
2. Signal Transduction
The ER is integral to various signaling pathways, particularly those involving calcium ions.
3. Metabolic Processes
The ER is involved in essential metabolic processes, including lipid metabolism and
detoxification, which are vital for cell survival and function.
4. Disease and Disorders
Disruptions in ER function can lead to various diseases and disorders:
ER Stress: Accumulation of misfolded proteins in the ER can lead to ER stress and
trigger the unfolded protein response (UPR), which is implicated in diseases such as
diabetes, neurodegeneration, and cancer.
Lipid Metabolism Disorders: Defects in lipid metabolism can lead to conditions such as
fatty liver disease and atherosclerosis.
Techniques for Studying the Endoplasmic Reticulum
1. Electron Microscopy
Electron microscopy provides detailed images of the ER's structure and organization within cells.
2. Fluorescence Microscopy
Fluorescently tagged proteins allow for the visualization of ER dynamics and interactions with
other organelles.
3. Biochemical Assays
Biochemical assays can measure the activity of ER enzymes involved in protein folding, lipid
synthesis, and detoxification.
4. Genetic Manipulation
Gene editing tools like CRISPR/Cas9 enable the study of the effects of specific genes on ER
function and related cellular processes.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
ER-Associated Degradation (ERAD)
ERAD is a quality control mechanism that identifies and targets misfolded or improperly
assembled proteins in the ER for degradation. Key steps include:
1. Recognition: Misfolded proteins are recognized by chaperones and lectins within the ER.
2. Retrotranslocation: The misfolded proteins are translocated back across the ER
membrane into the cytosol.
3. Ubiquitination: Once in the cytosol, the proteins are tagged with ubiquitin molecules,
marking them for degradation.
4. Proteasomal Degradation: Ubiquitinated proteins are directed to the proteasome, where
they are degraded into small peptides.
Unfolded Protein Response (UPR)
The UPR is activated in response to the accumulation of unfolded or misfolded proteins in the
ER, aiming to restore normal function by:
1. Transcriptional Activation: Upregulating genes encoding chaperones and components
of the ERAD pathway to enhance protein folding capacity and degradation.
2. Translational Attenuation: Temporarily reducing overall protein synthesis to decrease
the load of new proteins entering the ER.
3. Apoptosis: If homeostasis cannot be restored, prolonged UPR activation can trigger
programmed cell death (apoptosis) to protect the organism.
The UPR involves three main signaling pathways mediated by:
IRE1 (Inositol-Requiring Enzyme 1): Splices XBP1 mRNA, producing a transcription
factor that upregulates UPR target genes.
PERK (Protein Kinase R-like ER Kinase): Phosphorylates eIF2α, reducing general
protein synthesis while selectively translating ATF4, a transcription factor promoting
UPR gene expression.
ATF6 (Activating Transcription Factor 6): Translocates to the Golgi upon ER stress,
where it is cleaved to release a cytoplasmic fragment that acts as a transcription factor.
Inter-Organelle Communication
The ER interacts closely with other cellular organelles to coordinate various functions:
1. ER-Golgi Transport: Proteins and lipids synthesized in the ER are transported to the
Golgi apparatus for further processing and sorting.
2. ER-Mitochondria Contact Sites: These sites facilitate lipid transfer, calcium signaling,
and the regulation of apoptosis between the ER and mitochondria.
3. ER-Plasma Membrane Junctions: Involved in lipid transfer and calcium signaling,
affecting cellular metabolism and membrane dynamics.
4. ER-Lysosome Interactions: Important for the degradation of ER components through
autophagy (ER-phagy).
ER in Disease
Disruptions in ER function are linked to various diseases:
1. Neurodegenerative Diseases: ER stress and impaired UPR contribute to the
pathogenesis of diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral
sclerosis (ALS).
2. Diabetes: ER stress in pancreatic β-cells can lead to insulin resistance and β-cell
apoptosis, contributing to type 2 diabetes.
3. Cancer: Cancer cells often experience elevated ER stress due to rapid growth and
metabolic demands. They adapt by upregulating UPR pathways, which can contribute to
tumor survival and resistance to therapy.
Recent Research and Future Directions
1. ER Stress and Inflammation: Understanding the links between ER stress and
inflammatory pathways can uncover new therapeutic targets for chronic inflammatory
diseases.
2. Therapeutic Targeting of the UPR: Modulating UPR pathways offers potential
strategies for treating diseases associated with ER stress, such as developing small
molecules that enhance or inhibit specific UPR branches.
3. ER-Mitochondria Crosstalk: Investigating the molecular mechanisms underlying ER-
mitochondria interactions may reveal novel insights into metabolic regulation and
apoptosis.
4. ER-Phagy: Exploring the mechanisms and regulation of ER-phagy can provide new
understanding of cellular homeostasis and disease.
References
Alberts, B. et al. (2015). Molecular Biology of the Cell. 6th ed. Garland Science.
Lodish, H. et al. (2016). Molecular Cell Biology. 8th ed. W.H. Freeman and Company.
Cooper, G.M., Hausman, R.E. (2013). The Cell: A Molecular Approach. 6th ed. Sinauer
Associates.
Voeltz, G.K., & Barr, F.A. (2013). The structure and function of the endoplasmic
reticulum. Cold Spring Harbor Perspectives in Biology, 5(7), a013227.
